Advanced imaging for transseptal guidance — the multimodality imaging integration combining fluoroscopy, intracardiac echocardiography, transesophageal echo, and CT fusion imaging to optimize transseptal puncture planning and execution — represents the imaging technology investment that has transformed transseptal safety and precision, with the Transseptal Access System Market reflecting imaging guidance as a critical quality and safety market driver.

CT-fluoroscopy fusion for structural heart planning — the pre-procedural cardiac CT three-dimensional reconstruction overlaid on real-time fluoroscopy during structural heart procedures enabling anatomically guided transseptal puncture based on pre-procedure CT anatomy — represents the advanced imaging integration transforming complex structural heart procedure planning. The specific CT-based anatomical measurements for optimal MitraClip crossing height and LAAO optimal crossing location, translated into fluoroscopic guidance overlays, reduce the dependence on echocardiographic interpretation during procedures.

Electroanatomical mapping system integration — the CARTO 3 (Biosense Webster) and EnSite X (Abbott) electroanatomical mapping systems providing three-dimensional cardiac chamber reconstruction that can integrate with ICE imaging and pre-procedure CT — creates the navigation platform for complex transseptal procedures within electrophysiology. The ability to visualize the transseptal access catheter position within three-dimensional left atrial anatomy improves navigation confidence during complex AF substrate modification procedures.

Robotic catheter navigation and transseptal guidance — the Stereotaxis Niobe magnetic navigation and Corindus Corpath robotic coronary systems being investigated for transseptal applications — represent the robotic guidance frontier for transseptal procedures. The radiation protection benefit for operators performing high-volume transseptal procedures (AF ablation operators potentially performing two hundred-plus procedures annually) and the precision benefit for specific targeting in complex anatomy create the clinical rationale for robotic transseptal guidance investigation.

Do you think CT-fluoroscopy fusion imaging will become standard for all structural heart transseptal procedures, or will the additional planning time, radiation exposure, and contrast requirements limit CT fusion to the most complex structural cases?

FAQ

How does CT-fluoroscopy fusion improve transseptal access? CT fusion for structural heart transseptal guidance: Pre-procedure CT: gated cardiac CT providing three-dimensional anatomical model; aortic root relationship to interatrial septum; fossa ovalis location and thickness; mitral valve geometry; LAA anatomy and dimensions; pulmonary vein ostia for AF ablation; Fusion technology: CT three-dimensional reconstruction imported into cath lab workstation; registration with live fluoroscopy using anatomical landmarks (aortic root, spine, diaphragm); overlay display: CT anatomy projected onto fluoroscopic image; needle position visible relative to three-dimensional CT anatomy; specific benefits: optimal crossing location identification based on three-dimensional anatomy; distance from aorta measured on CT before needle advancement; MitraClip height determination from CT mitral valve geometry; Watchman size selection from CT LAA measurements; Navigation: three-dimensional needle tip position relative to fossa ovalis; real-time confirmation of crossing location; Commercial systems: Siemens syngo TrueFusion; Philips EchoNavigator (echo-fluoro fusion); GE CardIQ Xpress; DynaCT registration; Limitations: CT contrast and radiation from pre-procedure study; registration accuracy critical; patient movement causing registration drift; additional workflow time; validated for reduction in procedure time and complications in high-volume centers.

What is EchoNavigator and how does it assist structural heart procedures? Philips EchoNavigator system: Integration platform combining fluoroscopy and echocardiography; real-time overlay of echocardiographic images onto fluoroscopic images; simultaneous display of both imaging modalities on single screen; Transseptal application: TEE probe visualization on fluoroscopy confirms accurate echo plane selection; ICE catheter position visible relative to fluoro anatomy; needle position confirmed simultaneously by echo and fluoro; structural applications: MitraClip: clip position in relationship to leaflets shown on combined image; device delivery tracking; Watchman: device positioning in LAA with combined imaging confirmation; ASD closure: defect and device visualization simultaneously; Technical mechanism: electromagnetic field tracking of echo probe and fluoroscopic image; software registration; synchronized display; benefits: eliminates "back and forth" between separate echo and fluoroscopy displays; improves efficiency; reduces procedure time; studies showing reduced fluoroscopy time with EchoNavigator for MitraClip; competing systems: Siemens ACUSON OneSight; GE Vivid Echo with cath lab integration; development direction: full three-dimensional ICE integration with fluoroscopy; AI-guided overlay.

#TransseptalAccess #CTfluoroscopy #EchoNavigator #TransseptalGuidance #StructuralHeartImaging #FusionImaging